Immune Globulin Intravenous (Human), 10% Liquid (Privigen)
Immune Globulin Intravenous (Human), 10% Liquid is an FDA-licensed reference biologic from CSL Behring AG. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2007
Reference approved
Reference product
Privigen Immune Globulin Intravenous (Human), 10% Liquid
CSL Behring AG
- Approved
- Jul 26, 2007
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Immune Globulin Intravenous (Human), 10% Liquid, in chronological order.
Reference approval
Approval date of the reference Immune Globulin Intravenous (Human), 10% Liquid product.
19 yr 2 mo ago
Frequently asked questions
Are there biosimilars approved for Immune Globulin Intravenous (Human), 10% Liquid (Privigen)?
No 351(k) biosimilars or interchangeable biosimilars referencing Immune Globulin Intravenous (Human), 10% Liquid are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.